ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

In Brief: Levin Leaves UCSF for M.D. Anderson; Copeland Moves to Ohio State; OC’s Alice Hamm Retires

July 1, 1988

Poland Knights Peto, Boyle; Mihich Wins Tomasi Award.

February 2, 2001

FY 1984 Bypass Budget Shown By Mechanism,, Research Program

July 2, 1982

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974